Cash cost of the wait: management is funding a defined waiting period whose end is already scheduled
The model's full reasoning — Q4 2017 call → NOThe question asks whether management describes the company as currently living through a defined waiting period it is paying for out of its own pocket — with three conditions: (1) The company is paying now for something not yet earning. (2) Management speaks as though the wait is the company's main current work. (3) The far side is a specific, near-dated, already-visible event. Let me examine the transcript for evidence. Key themes in the call: - UK operations: agency labor costs, census issues, NHS transition. The UK is going through a transition process where local areas determine patient flow. Management says it will take another year for these local communities to fully transition. This is presented as a challenge, not as a self-funded waiting period. The agency labor costs are being managed, but this is more of an external issue (nursing shortage) and a management problem, not a "paying now for something not yet earning" situation. - New beds added: 750 beds in 2017, 800+ expected in 2018. These are bed additions to existing facilities and new facilities (de novos). The de novos have losses — $1.8 million loss in Q4, $2.1 million expected in Q1. These are new facilities ramping up. Management discusses de novo losses as part of guidance. But is this presented as "the company's main current work" with a specific near-dated event? The de novos are opening and ramping. The losses are expected to be breakeven to slightly profitable by second half of 2018. This could fit — the company is paying for new facilities (de novos) that aren't yet earning, and the ramp is expected within the year. However, let me look more carefully. The de novo losses are relatively small ($1.8M in Q4, $2.1M in Q1) compared to revenue of $724M. The company's main focus seems to be on UK operations, which are struggling due to external factors (NHS transition, nursing shortage) — not a self-funded waiting period. The question asks for ONE coherent situation where all three conditions come through as present-tense reality. Let me check each condition: (1) Paying now for something not yet earning: The de novos are being built/opened and have losses. The company is funding these. Also, the bed additions to existing facilities — these are being added and ramping.
| Ticker | Company | Call | Date | Call grade |
|---|---|---|---|---|
| KOPN | Kopin Corporation | Q4 2023 | 2024-03-14 | C+ |
| LILA | Liberty Latin America Ltd. | Q4 2023 | 2024-02-23 | C |
| SBS | Companhia de Saneamento Básico do Estado | Q3 2023 | 2023-11-10 | C+ |
| QTRX | Quanterix Corporation | Q3 2023 | 2023-11-07 | B |
| APPS | Digital Turbine, Inc. | Q1 2024 | 2023-08-08 | D |
| PRPH | ProPhase Labs, Inc. | Q1 2023 | 2023-05-11 | F |
| CDE | Coeur Mining, Inc. | Q1 2023 | 2023-05-11 | C+ |
| SOL | ReneSola Ltd | Q3 2022 | 2022-12-01 | C+ |
| FLL | Full House Resorts, Inc. | Q3 2022 | 2022-11-07 | B |
| EHTH | eHealth, Inc. | Q2 2021 | 2021-07-29 | F |
| IRT | Independence Realty Trust, Inc. | Q2 2018 | 2018-08-02 | B |
| YUM | Yum! Brands, Inc. | Q2 2018 | 2018-08-02 | C |
| IBTX | Independent Bank Group, Inc. | Q3 2017 | 2017-10-24 | A |
| FLEX | Flex Ltd. | Q1 2018 | 2017-07-28 | F |
| DAN | Dana Incorporated | Q1 2017 | 2017-05-02 | B |
SBS · Q3 2023 → YESThe question is whether management describes the company as currently living through a defined waiting period it's paying for out of its own pocket. YES The transcript shows management describing the company as currently bearing real, ongoing cash costs (salaries, consulting, transition work) for the IDP/restructuring program whose benefits (full expense reduction, shared-services center operational) are not yet realized. The far side is a specific, near-dated event: full 3.7% staff reduction and shared-services center operational by mid-2024 (July 2024 for full benefit), with the program already in motion and on schedule. Management frames this as the main current work, not a setback, and treats the costs as self-funded. This meets all three conditions.
EHTH · Q2 2021 → YESThe question is whether management describes the company as currently living through a defined waiting period it is paying for out of its own pocket. YES The transcript shows management describing the company as currently living through a defined waiting period for the AEP, paying for it out of its own pocket through heavy investments in internal agents and quality initiatives. They hired agents early, many still in training with lower productivity, and are bearing the cost of additional training and customer service expansion in Q3. This is framed as a chosen investment to improve enrollment quality and prepare for the fourth-quarter AEP, not an apology or external issue.
YUM · Q2 2018 → YESThe question is whether management describes the company as currently living through a defined waiting period it is paying for out of its own pocket. YES The transcript shows management describing a clear, self-funded transition cost tied to the refranchising effort. They explicitly call out the “timing mismatch between G&A savings and refranchising” as one of the four items weighing on Q2 core operating profit, and they quantify the full-year headwind at 6 7 percentage points. This is presented as a real, ongoing drag on current results while they complete the shift to 98 % franchised by year-end 2018 and reach the 1.7 % G&A run-rate target in 2019.